Skip to main content

Lloyd’s Lab and Bermuda Monetary Authority celebrate successes of Bermuda cohort

13 Jun 2025

Lloyd’s, the world’s leading insurance and reinsurance market for global risk in collaboration with the Bermuda Monetary Authority (Authority or BMA),  brought together industry leaders and innovators  with Bermuda-based reinsurance professionals to mark the pioneering achievements of Lloyd’s Lab Accelerator Cohort 14 at an event in Bermuda.

The Premier of Bermuda, David Burt, opened the event echoing the remarks made by Craig Swan, CEO of the BMA, emphasising the collaborative partnership between Lloyd’s and the BMA, allowing innovators to work together to provide solutions and unlock capacity for tomorrow’s risks.

As part of the events, the BMA hosted an exclusive roundtable and workshop for senior representatives from the BMA and Lloyd's Lab to work alongside experienced mentors and representatives from Cohort 14 of the programme; Supercede, 7Analytics and Tailshift (formerly Unwind Finance). Demonstrating the significant progress made across  ten weeks, the session took an in-depth look at the latest cohort’s product development, and the collaborative opportunities for further advancing their solutions within Bermuda's dynamic reinsurance ecosystem and beyond.

"Our partnership with the BMA exemplifies how regulatory collaboration can accelerate innovation in reinsurance. Cohort 14's success in Bermuda demonstrates the power of bringing together regulators, established market leaders, and emerging innovators to tackle the industry's most pressing challenges in building a resilient future."
Rosie Denée, Head of Innovation, Commercial Education and Events at Lloyd’s
“The successful partnership between the BMA and Lloyd’s highlights the vital role that industry knowledge sharing and mutual collaboration play in driving innovation across Bermuda’s financial landscape. The achievements of Cohort 14 highlight the transformative potential of technology and innovative thinking in addressing emerging risks and providing proactive solutions for future challenges.”
Craig Swan, CEO of the BMA